Advertisement

Topics

Study to Test an Approved Product in the Early Treatment of Migraine

2014-08-27 03:54:00 | BioPortfolio

Summary

The purpose of this study is to test the effectiveness of an approved drug in the early treatment of migraine while the pain is still mild.

Study Design

Allocation: Randomized, Control: Placebo Control, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Conditions

Migraine

Intervention

MK0462, rizatriptan benzoate / Duration of Treatment: 1day, Comparator: placebo / Duration of Treatment: 1 day

Status

Completed

Source

Merck

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-08-27T03:54:00-0400

Clinical Trials [1044 Associated Clinical Trials listed on BioPortfolio]

MK0462 in Treatment of Migraine With Recurrence

A study to evaluate rizatriptan/MK0462(5 and 10 mg) for the treatment of acute migraine attack and treatment of up to two headache recurrences compared to placebo.

MK0462 5 mg, Sumatriptan 50 mg, and Placebo Comparison Study

A study to compare rizatriptan (MK0462) 5 mg p.o. (by mouth) and sumatriptan 50 mg p.o. for the acute treatment of a migraine attack.

Study to Test a Marketed Drug in the Treatment of Menstrual Migraine

The purpose of this study is to test the effectiveness of a marketed drug in the treatment of a menstrual migraine attack.

Study to Test an Approved Product in the Early Treatment of Migraine

The purpose of this study is to test the effectiveness of an approved drug in the early treatment of migraine.

Study to Test a Marketed Drug in the Treatment of Menstrual Migraine

The purpose of this study is to test the effectiveness of a marketed drug in the treatment of a menstrual migraine attack.

PubMed Articles [18655 Associated PubMed Articles listed on BioPortfolio]

Placebo acceptability in chronic pain patients: More dependent on application mode and resulting condition than on individual factors.

Placebo effects can be very effective in certain pain conditions, but their use is still highly controversial. Several studies show that patients would accept a placebo treatment under certain circums...

A randomized clinical trial of the effectiveness of 0.018-inch and 0.022-inch slot orthodontic bracket systems: part 1-duration of treatment.

To compare treatment duration between 0.018-inch and 0.022-inch slot systems and determine factors influencing treatment duration.

Believe in what you practice.

A recent meta-analysis showed that antidepressants are more effective than placebo. In placebo-controlled trials, the placebo effect is subtracted from the verum effect to find the specific effect of ...

Tramadol Hydrochloride at Steady State Lacks Clinically Relevant QTc Interval Increases in Healthy Adults.

We evaluated the effects of therapeutic and supratherapeutic doses of tramadol hydrochloride on the corrected QT (QTc) interval in healthy adults (aged 18-55 years) in a randomized, phase I, double-b...

Decreasing Treatment Duration of Electroconvulsive Therapy (ECT) Using Daily Right Unilateral Ultrabrief Instead of Bitemporal ECT.

Electroconvulsive therapy (ECT) is an effective treatment for depression, but the standard 2 to 3 times weekly treatment course results in a total treatment duration of >2 weeks. We explored the viabi...

Medical and Biotech [MESH] Definitions

An enzyme that catalyzes the oxidation of BENZOATE to 4-hydroxybenzoate. It requires IRON and tetrahydropteridine.

Misunderstanding among individuals, frequently research subjects, of scientific methods such as randomization and placebo controls.

A narcotic analgesic with a long onset and duration of action. It is used mainly in the treatment of narcotic dependence.

A cholinesterase inhibitor with a slightly longer duration of action than NEOSTIGMINE. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants.

An ADRENERGIC BETA-2 RECEPTOR AGONIST with a prolonged duration of action. It is used to manage ASTHMA and in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.

More From BioPortfolio on "Study to Test an Approved Product in the Early Treatment of Migraine"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Anesthesiology
An anesthesiologist (US English) or anaesthetist (British English) is a physician trained in anesthesia and perioperative medicine. Anesthesiologists are physicians who provide medical care to patients in a wide variety of (usually acute) situations. ...


Searches Linking to this Trial